Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
about
Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoformsCytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophilsHigh- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophilsGeneration of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteasesMonocyte-derived CXCL7 peptides in the marrow microenvironmentEmerging roles for platelets as immune and inflammatory cellsThe crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolutionCXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factorMolecular evolution of the human interleukin-8 receptor gene clusterInduction and antimicrobial activity of platelet basic protein derivatives in human monocytes.Megakaryocyte maturation is associated with expression of the CXC chemokine connective tissue-activating peptide CTAP III.Biological activity of CXCL8 forms generated by alternative cleavage of the signal peptide or by aminopeptidase-mediated truncation.Antimicrobial peptides from human plateletsDifferent functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2.The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic miceRetinoic acid receptor-dependent, cell-autonomous, endogenous retinoic acid signaling and its target genes in mouse collecting duct cells.Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines.Early postmyocardial infarction survival in Murphy Roths Large mice is mediated by attenuated apoptosis and inflammation but depends on genetic backgroundIncreased microvascular permeability in vivo in response to intradermal injection of neutrophil-activating protein (NAP-2) in rabbit skin.Bovine ENA, a new monocyte-macrophage derived cytokine of the interleukin-8 family. Structure, function, and expression in acute pulmonary inflammationPlatelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg.Identification of RANTES receptors on human monocytic cells: competition for binding and desensitization by homologous chemotactic cytokinesIP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cellsA recipe for designing water-soluble, beta-sheet-forming peptides.Chemerin reveals its chimeric natureRole of platelet chemokines, PF-4 and CTAP-III, in cancer biology.Platelet chemokines in vascular disease.Platelet alpha-granules: basic biology and clinical correlates.Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]).Cytokines in terms of QSAR. Review, evaluation and comparative studies.Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2). Comparison of native and recombinant NAP-2 variants.Platelets in leucocyte recruitment and function.CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.Platelets in neutrophil recruitment to sites of inflammation.Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha.Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III.Chemokines, a family of chemotactic cytokines.Chemokines and tissue injuryDo chemokines mediate inflammatory cell invasion of the central nervous system parenchyma?
P2860
Q22009107-6B7147C2-8518-4B98-B02E-184A7A65F46EQ24293111-485C5BAE-2546-44FF-A9B0-42DBB8ED269FQ24563339-96A2D78C-54B2-4FAB-8861-DDD8AB3F08E0Q24683088-9D71CCF4-4573-4D5D-A596-B58B7A286461Q24685690-E5D960FD-6DC4-4AAD-ACF3-B0EDE6D943CDQ27016553-25D97972-CDF3-4810-A62D-0288E4DA3166Q27729945-3E2949D7-7DB5-42EA-BAC7-0CC530980B34Q28116204-FF90C412-C786-46F1-A336-E8952CF1C9F0Q28208052-5FC5F9CE-79BB-4ADA-B5D2-D5E8C39BAA03Q33206053-9DBD46C9-0B35-44BC-9F20-BDD932E6C62EQ33335794-BD3A01AD-04B2-4D7D-9B5A-31B78C67FC75Q34014452-EA01698E-2A83-4B55-9F2F-9AAEDFEF90ECQ34258124-C77929B0-8284-41A3-8FC7-5B8AD30F84F4Q34387572-187BE7F4-3DC1-4F54-9BFB-4471F332F0C5Q34433231-6A89BD14-52BC-4E77-8BA1-6CE2AB863B72Q34438349-0388DCC1-9C2B-4474-8354-FDC83E2ACC28Q35592746-FC46F93C-5587-4423-ACF1-0CAFD9A5FF4EQ35659123-FD8CE4DE-649A-49B5-93FE-EDDFCE7CB0BDQ35830397-800B63C5-121A-4D28-B4AD-F5FBAF361486Q35834281-32772F0F-204F-4E02-9218-0423FFCB788CQ36251731-263331CF-D242-4165-A5FD-45D04F602124Q36361364-F2B12D8D-9F70-4B01-87C6-90DC2F44F1A0Q36362293-7DB36534-B284-4C89-A217-85CA31A33219Q36768315-EFCE6BC0-DF83-488C-965A-06A89D3E0B89Q36821196-198F9A94-89A0-4519-A3EA-B401B8DA32D6Q36916411-AF0FF80D-CB0E-4FDC-9C15-39946F5BBB3AQ36960001-D3BE35C7-CA98-4E7D-B417-4ABB267DD2A2Q37131719-D1D1A94A-C311-4FDE-8998-B5C72B587720Q37487079-66218BD1-1D7B-41D0-AC72-A8663CFD7F31Q37926949-BE3E569C-EF69-4473-9E1E-4E4D7360BA77Q38149987-D55D1BDF-BF2B-450F-B6A2-A9765B3D8EBCQ38297496-FABB7737-FF1E-457D-8B9A-12429B860B80Q38364980-F13017FB-3C91-47E2-94F3-CAE6FC47FA3CQ38690194-93A8A889-4A56-48B4-BA88-A1B44890C202Q39001947-3F53E9EE-2F88-4B36-ADBF-22F9A5F89703Q39369867-F15E16B4-8D0B-4FF3-A383-E249F7EFFE21Q40347131-C9F4ED8B-DE07-4FF2-A21B-B9FD4D097ED8Q40406074-3B3D9815-824B-4406-8A9A-EDD5087A52FEQ40543142-0A7CCA23-68E8-4F71-A63A-DE8FF238D5B1Q40689750-511537C0-6139-42DE-99C8-A60A2FF630E0
P2860
Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Effects of the neutrophil-acti ...... factor 4 on human neutrophils.
@ast
Effects of the neutrophil-acti ...... factor 4 on human neutrophils.
@en
type
label
Effects of the neutrophil-acti ...... factor 4 on human neutrophils.
@ast
Effects of the neutrophil-acti ...... factor 4 on human neutrophils.
@en
prefLabel
Effects of the neutrophil-acti ...... factor 4 on human neutrophils.
@ast
Effects of the neutrophil-acti ...... factor 4 on human neutrophils.
@en
P2093
P2860
P356
P1476
Effects of the neutrophil-acti ...... factor 4 on human neutrophils.
@en
P2093
Baggiolini M
von Tscharner V
P2860
P304
P356
10.1084/JEM.170.5.1745
P407
P577
1989-11-01T00:00:00Z